Email bookmark
Font : A-A+

Drug information on Montlu-L (Montelukast) from Shince Pharmaceuticals Pvt. Ltd.

Montlu-L

  Tablet  
Shince Pharmaceuticals Pvt. Ltd.
Generic : Montelukast
 119.00
10mg/5mg
10
Medindia currently has information on 3065 generic drugs and 109,997 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us (info@medindia.net) if a drug is missing from our comprehensive drug price list.

Medical Condition(s) for which Montlu-L may be prescribed


Side effects of Montlu-L

   Most Common : Diarrhea, dizziness, cough, headache, vomiting, stomach pain and sore throat.

   Miscellaneous : Hoarseness, itching, rash, hives, fever, flu-like symptoms, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

Dosage & When it is to be taken (Indications)

Adult- PO- The recommended dose is 10 mg/day.

How to use Montlu-L?

It comes as a tablet to take by mouth with or without food.

When is Montlu-L not to be taken? (Contraindications)

Hypersensitivity.

Warnings and Precautions for Montlu-L

Caution should be exercised in patients with history of liver disease, suicidal thoughts, mental problem, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause drowsiness or dizziness, do not drive a car or operate machinery while taking this medication.

Other Precautions for Montlu-L

Avoid excess dosage.

Storage Conditions for Montlu-L

Store it at controlled room temperature (15-30°C).

♦ Safety Labeling Changes Approved By FDA



Disclaimer : The Price of the drugs indicated above may not match the actual price at which they are sold. Prices can change depending on many factors, including GST. These are only approximate indicative prices of the drug.
Buy Medicines (Drug) at Concessional Price from India
Substitutes for Montlu-L

View all
Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.